Aeron C Hurt

InstitutionUniversity of Melbourne
AddressAustralia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 2 Covid-19 publications, with a maximum of 1 publications in October 2020 and April 2021
    All Publications
    Bar chart showing 98 publications over 19 distinct years, with a maximum of 10 publications in 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hurt AC, Wheatley AK. Neutralizing Antibody Therapeutics for COVID-19. Viruses. 2021 04 07; 13(4). PMID: 33916927.
      Citations: 16     Fields:    Translation:Humans
    2. Chotpitayasunondh T, Fischer TK, Heraud JM, Hurt AC, Monto AS, Osterhaus A, Shu Y, Tam JS. Influenza and COVID-19: What does co-existence mean? Influenza Other Respir Viruses. 2021 05; 15(3):407-412. PMID: 33128444.
      Citations: 8     Fields:    Translation:Humans
    3. Wille M, Shi M, Klaassen M, Hurt AC, Holmes EC. Virome heterogeneity and connectivity in waterfowl and shorebird communities. ISME J. 2019 10; 13(10):2603-2616. PMID: 31239538.
      Citations: 23     Fields:    Translation:AnimalsCells
    4. Suttie A, Karlsson EA, Deng YM, Hurt AC, Greenhill AR, Barr IG, Dussart P, Horwood PF. Avian influenza in the Greater Mekong Subregion, 2003-2018. Infect Genet Evol. 2019 10; 74:103920. PMID: 31201870.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    5. Kode SS, Pawar SD, Tare DS, Keng SS, Hurt AC, Mullick J. A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivir. Vet Microbiol. 2019 Aug; 235:21-24. PMID: 31282375.
      Citations: 5     Fields:    Translation:AnimalsCells
    6. Wille M, Aban M, Wang J, Moore N, Shan S, Marshall J, González-Acuña D, Vijaykrishna D, Butler J, Wang J, Hall RJ, Williams DT, Hurt AC. Antarctic Penguins as Reservoirs of Diversity for Avian Avulaviruses. J Virol. 2019 06 01; 93(11). PMID: 30894472.
      Citations: 8     Fields:    Translation:AnimalsCells
    7. Hurt AC. Antiviral Therapy for the Next Influenza Pandemic. Trop Med Infect Dis. 2019 Apr 18; 4(2). PMID: 31003518.
      Citations: 9     
    8. Koutsakos M, Illing PT, Nguyen THO, Mifsud NA, Crawford JC, Rizzetto S, Eltahla AA, Clemens EB, Sant S, Chua BY, Wong CY, Allen EK, Teng D, Dash P, Boyd DF, Grzelak L, Zeng W, Hurt AC, Barr I, Rockman S, Jackson DC, Kotsimbos TC, Cheng AC, Richards M, Westall GP, Loudovaris T, Mannering SI, Elliott M, Tangye SG, Wakim LM, Rossjohn J, Vijaykrishna D, Luciani F, Thomas PG, Gras S, Purcell AW, Kedzierska K. Human CD8+ T cell cross-reactivity across influenza A, B and C viruses. Nat Immunol. 2019 05; 20(5):613-625. PMID: 30778243.
      Citations: 69     Fields:    Translation:HumansAnimalsCells
    9. Koszalka P, Tilmanis D, Roe M, Vijaykrishna D, Hurt AC. Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018. Antiviral Res. 2019 04; 164:91-96. PMID: 30771405.
      Citations: 17     Fields:    Translation:Cells
    10. Lee N, Hurt AC. Neuraminidase inhibitor resistance in influenza: a clinical perspective. Curr Opin Infect Dis. 2018 12; 31(6):520-526. PMID: 30299356.
      Citations: 17     Fields:    Translation:HumansCells
    11. Mifsud EJ, Tai CM, Hurt AC. Animal models used to assess influenza antivirals. Expert Opin Drug Discov. 2018 12; 13(12):1131-1139. PMID: 30362841.
      Citations: 6     Fields:    Translation:HumansAnimals
    12. Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med. 2018 09 06; 379(10):913-923. PMID: 30184455.
      Citations: 168     Fields:    Translation:HumansCTClinical Trials
    13. Suttie A, Karlsson EA, Deng YM, Horm SV, Yann S, Tok S, Sorn S, Holl D, Tum S, Hurt AC, Greenhill AR, Barr IG, Horwood PF, Dussart P. Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets. Virology. 2018 10; 523:22-26. PMID: 30075357.
      Citations: 5     Fields:    Translation:AnimalsCells
    14. Lee LYY, Izzard L, Hurt AC. A Review of DNA Vaccines Against Influenza. Front Immunol. 2018; 9:1568. PMID: 30038621.
      Citations: 28     Fields:    
    15. Lackenby A, Besselaar TG, Daniels RS, Fry A, Gregory V, Gubareva LV, Huang W, Hurt AC, Leang SK, Lee RTC, Lo J, Lollis L, Maurer-Stroh S, Odagiri T, Pereyaslov D, Takashita E, Wang D, Zhang W, Meijer A. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017. Antiviral Res. 2018 09; 157:38-46. PMID: 29981793.
      Citations: 28     Fields:    Translation:HumansCells
    16. Matos AR, Resende PC, Miranda MD, Garcia CC, Caetano BC, Lopes JCO, Debur MC, Cury ALF, Vianna LA, Lima MC, Schirmer M, Gubareva L, Hurt AC, Brown DW, Siqueira MM. Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile. Antiviral Res. 2018 06; 154:35-43. PMID: 29601892.
      Citations: 3     Fields:    Translation:HumansCells
    17. Koutsakos M, Wheatley AK, Loh L, Clemens EB, Sant S, Nüssing S, Fox A, Chung AW, Laurie KL, Hurt AC, Rockman S, Lappas M, Loudovaris T, Mannering SI, Westall GP, Elliot M, Tangye SG, Wakim LM, Kent SJ, Nguyen THO, Kedzierska K. Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity. Sci Transl Med. 2018 02 14; 10(428). PMID: 29444980.
      Citations: 63     Fields:    Translation:HumansCellsPHPublic Health
    18. Oh DY, Panozzo J, Vitesnik S, Farrukee R, Piedrafita D, Mosse J, Hurt AC. Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets. Antivir Ther. 2018; 23(4):295-306. PMID: 28195559.
      Citations: 4     Fields:    Translation:AnimalsCells
    19. Tilmanis D, van Baalen C, Oh DY, Rossignol JF, Hurt AC. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide. Antiviral Res. 2017 Nov; 147:142-148. PMID: 28986103.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    20. Hurt AC, Subbarao K. New options to treat influenza B. Nat Microbiol. 2017 10; 2(10):1342-1343. PMID: 29046530.
      Citations:    Fields:    Translation:HumansAnimalsCells
    21. Gubareva LV, Besselaar TG, Daniels RS, Fry A, Gregory V, Huang W, Hurt AC, Jorquera PA, Lackenby A, Leang SK, Lo J, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Odagiri T, Wang D, Zhang W, Meijer A. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016. Antiviral Res. 2017 Oct; 146:12-20. PMID: 28802866.
      Citations: 29     Fields:    Translation:HumansCells
    22. Vanderven HA, Liu L, Ana-Sosa-Batiz F, Nguyen TH, Wan Y, Wines B, Hogarth PM, Tilmanis D, Reynaldi A, Parsons MS, Hurt AC, Davenport MP, Kotsimbos T, Cheng AC, Kedzierska K, Zhang X, Xu J, Kent SJ. Fc functional antibodies in humans with severe H7N9 and seasonal influenza. JCI Insight. 2017 Jul 06; 2(13). PMID: 28679958.
      Citations: 16     Fields:    
    23. Leang SK, Hurt AC. Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals. J Vis Exp. 2017 04 15; (122). PMID: 28448045.
      Citations: 13     Fields:    Translation:Cells
    24. Allen RJ, Koutsakos M, Hurt AC, Kedzierska K. Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection. Am J Case Rep. 2017 Feb 22; 18:190-193. PMID: 28223680.
      Citations:    Fields:    Translation:HumansCells
    25. Lau H, Hurt AC. Assessment of the RNASound RNA Sampling Card for the Preservation of Influenza Virus RNA. Front Microbiol. 2016; 7:1736. PMID: 27853455.
      Citations: 3     
    26. Hurt AC, Su YCF, Aban M, Peck H, Lau H, Baas C, Deng YM, Spirason N, Ellström P, Hernandez J, Olsen B, Barr IG, Vijaykrishna D, Gonzalez-Acuna D. Evidence for the Introduction, Reassortment, and Persistence of Diverse Influenza A Viruses in Antarctica. J Virol. 2016 Nov 01; 90(21):9674-9682. PMID: 27535050.
      Citations: 11     Fields:    Translation:AnimalsCells
    27. Moss R, McCaw JM, Cheng AC, Hurt AC, McVernon J. Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context. BMC Infect Dis. 2016 Oct 10; 16(1):552. PMID: 27724915.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    28. Hurt AC, Besselaar TG, Daniels RS, Ermetal B, Fry A, Gubareva L, Huang W, Lackenby A, Lee RT, Lo J, Maurer-Stroh S, Nguyen HT, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Tashiro M, Tilmanis D, Wang D, Zhang W, Meijer A. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015. Antiviral Res. 2016 08; 132:178-85. PMID: 27265623.
      Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
    29. Hurt AC, Kelly H. Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza. Emerg Infect Dis. 2016 06; 22(6):949-55. PMID: 27191818.
      Citations: 14     Fields:    Translation:HumansCells
    30. Dalziel AE, Peck HA, Hurt AC, Cooke J, Cassey P. Proposed Surveillance for Influenza A in Feral Pigs. Ecohealth. 2016 06; 13(2):410-4. PMID: 27174429.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    31. Oh DY, Hurt AC. Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness. Front Microbiol. 2016; 7:80. PMID: 26870031.
      Citations: 29     
    32. Petrie SM, Butler J, Barr IG, McVernon J, Hurt AC, McCaw JM. Quantifying relative within-host replication fitness in influenza virus competition experiments. J Theor Biol. 2015 Oct 07; 382:259-71. PMID: 26188087.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    33. Bird NL, Olson MR, Hurt AC, Oshansky CM, Oh DY, Reading PC, Chua BY, Sun Y, Tang L, Handel A, Jackson DC, Turner SJ, Thomas PG, Kedzierska K. Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses. PLoS One. 2015; 10(6):e0129768. PMID: 26086392.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    34. Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, Klimov A, Lewis NS, Li X, McCauley JW, Odagiri T, Potdar V, Rambaut A, Shu Y, Skepner E, Smith DJ, Suchard MA, Tashiro M, Wang D, Xu X, Lemey P, Russell CA. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 2015 Jul 09; 523(7559):217-20. PMID: 26053121.
      Citations: 161     Fields:    Translation:HumansCells
    35. Panozzo J, Oh DY, Margo K, Morton DA, Piedrafita D, Mosse J, Hurt AC. Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infection. Antiviral Res. 2015 Aug; 120:66-71. PMID: 26022199.
      Citations: 3     Fields:    Translation:Animals
    36. Farrukee R, Leang SK, Butler J, Lee RT, Maurer-Stroh S, Tilmanis D, Sullivan S, Mosse J, Barr IG, Hurt AC. Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility. J Antimicrob Chemother. 2015 Jul; 70(7):2004-12. PMID: 25786478.
      Citations: 5     Fields:    Translation:Cells
    37. Oh DY, Barr IG, Hurt AC. A novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity. PLoS One. 2015; 10(3):e0118780. PMID: 25738900.
      Citations: 9     Fields:    Translation:AnimalsCells
    38. Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, Fry A, Gregory V, Leang SK, Huang W, Lo J, Pereyaslov D, Siqueira MM, Wang D, Mak GC, Zhang W, Daniels RS, Hurt AC, Tashiro M. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014. Antiviral Res. 2015 May; 117:27-38. PMID: 25721488.
      Citations: 41     Fields:    Translation:HumansCellsPHPublic Health
    39. Lee HK, Tang JW, Loh TP, Hurt AC, Oon LL, Koay ES. Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013. PLoS One. 2015; 10(1):e0117822. PMID: 25635767.
      Citations: 4     Fields:    Translation:HumansCells
    40. Little K, Leang SK, Butler J, Baas C, Harrower B, Mosse J, Barr IG, Hurt AC. Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring. Euro Surveill. 2015; 20(45). PMID: 26608955.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    41. Hurt AC, Hui DS, Hay A, Hayden FG. Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management. Influenza Other Respir Viruses. 2015 Jan; 9(1):20-31. PMID: 25399715.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    42. Meijer A, Rebelo-de-Andrade H, Correia V, Besselaar T, Drager-Dayal R, Fry A, Gregory V, Gubareva L, Kageyama T, Lackenby A, Lo J, Odagiri T, Pereyaslov D, Siqueira MM, Takashita E, Tashiro M, Wang D, Wong S, Zhang W, Daniels RS, Hurt AC. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013. Antiviral Res. 2014 Oct; 110:31-41. PMID: 25043638.
      Citations: 31     Fields:    Translation:HumansCells
    43. Hurt AC. The epidemiology and spread of drug resistant human influenza viruses. Curr Opin Virol. 2014 Oct; 8:22-9. PMID: 24866471.
      Citations: 68     Fields:    Translation:HumansCells
    44. Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, Arkinstall R, Kelso A, Mcvernon J, Barr IG, Middleton D, Hurt AC. Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact. J Antimicrob Chemother. 2014 Sep; 69(9):2458-69. PMID: 24840623.
      Citations: 17     Fields:    Translation:HumansAnimalsPHPublic Health
    45. Carolan LA, Butler J, Rockman S, Guarnaccia T, Hurt AC, Reading P, Kelso A, Barr I, Laurie KL. TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses. J Virol Methods. 2014 09 01; 205:38-52. PMID: 24797460.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    46. Butler J, Hooper KA, Petrie S, Lee R, Maurer-Stroh S, Reh L, Guarnaccia T, Baas C, Xue L, Vitesnik S, Leang SK, McVernon J, Kelso A, Barr IG, McCaw JM, Bloom JD, Hurt AC. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. PLoS Pathog. 2014 Apr; 10(4):e1004065. PMID: 24699865.
      Citations: 53     Fields:    Translation:HumansAnimalsCells
    47. Oh DY, Hurt AC. A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade. Scientifica (Cairo). 2014; 2014:430629. PMID: 24800107.
      Citations: 15     
    48. Leang SK, Kwok S, Sullivan SG, Maurer-Stroh S, Kelso A, Barr IG, Hurt AC. Peramivir and laninamivir susceptibility of circulating influenza A and B viruses. Influenza Other Respir Viruses. 2014 Mar; 8(2):135-9. PMID: 24734292.
      Citations: 16     Fields:    Translation:HumansCells
    49. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science. 2013 Nov 22; 342(6161):976-9. PMID: 24264991.
      Citations: 213     Fields:    Translation:HumansCells
    50. Hurt AC, Ison MG, Hayden FG, Hay AJ. Second isirv antiviral group conference: overview. Influenza Other Respir Viruses. 2013 Nov; 7 Suppl 3:1-7. PMID: 24215376.
      Citations: 1     Fields:    Translation:HumansCells
    51. Doyle TM, Li C, Bucher DJ, Hashem AM, Van Domselaar G, Wang J, Farnsworth A, She YM, Cyr T, He R, Brown EG, Hurt AC, Li X. A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains. Biochem Biophys Res Commun. 2013 Nov 08; 441(1):226-9. PMID: 24140051.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    52. Jegaskanda S, Amarasena TH, Laurie KL, Tan HX, Butler J, Parsons MS, Alcantara S, Petravic J, Davenport MP, Hurt AC, Reading PC, Kent SJ. Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques. J Virol. 2013 Dec; 87(24):13706-18. PMID: 24109221.
      Citations: 24     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    53. Farrukee R, Mosse J, Hurt AC. Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses. Expert Rev Anti Infect Ther. 2013 Nov; 11(11):1135-45. PMID: 24093683.
      Citations: 10     Fields:    Translation:HumansCells
    54. Doyle TM, Hashem AM, Li C, Van Domselaar G, Larocque L, Wang J, Smith D, Cyr T, Farnsworth A, He R, Hurt AC, Brown EG, Li X. Universal anti-neuraminidase antibody inhibiting all influenza A subtypes. Antiviral Res. 2013 Nov; 100(2):567-74. PMID: 24091204.
      Citations: 51     Fields:    Translation:AnimalsCells
    55. Sam IC, Shaw R, Chan YF, Hooi PS, Hurt AC, Barr IG. Seroprevalence of seasonal and pandemic influenza a in Kuala Lumpur, Malaysia in 2008-2010. J Med Virol. 2013 Aug; 85(8):1420-5. PMID: 23765779.
      Citations: 3     Fields:    Translation:HumansCells
    56. Vijaykrishna D, Deng YM, Su YC, Fourment M, Iannello P, Arzey GG, Hansbro PM, Arzey KE, Kirkland PD, Warner S, O'Riley K, Barr IG, Smith GJ, Hurt AC. The recent establishment of North American H10 lineage influenza viruses in Australian wild waterfowl and the evolution of Australian avian influenza viruses. J Virol. 2013 Sep; 87(18):10182-9. PMID: 23864623.
      Citations: 16     Fields:    Translation:AnimalsCells
    57. Barr IG, Hurt AC. Double dose oseltamivir for severe influenza--does it help? BMJ. 2013 May 30; 346:f3449. PMID: 23723458.
      Citations:    Fields:    Translation:HumansCells
    58. Petrie SM, Guarnaccia T, Laurie KL, Hurt AC, McVernon J, McCaw JM. Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load. PLoS One. 2013; 8(5):e64098. PMID: 23691157.
      Citations: 17     Fields:    Translation:Animals
    59. Leang SK, Deng YM, Shaw R, Caldwell N, Iannello P, Komadina N, Buchy P, Chittaganpitch M, Dwyer DE, Fagan P, Gourinat AC, Hammill F, Horwood PF, Huang QS, Ip PK, Jennings L, Kesson A, Kok T, Kool JL, Levy A, Lin C, Lindsay K, Osman O, Papadakis G, Rahnamal F, Rawlinson W, Redden C, Ridgway J, Sam IC, Svobodova S, Tandoc A, Wickramasinghe G, Williamson J, Wilson N, Yusof MA, Kelso A, Barr IG, Hurt AC. Influenza antiviral resistance in the Asia-Pacific region during 2011. Antiviral Res. 2013 Feb; 97(2):206-10. PMID: 23274624.
      Citations: 18     Fields:    Translation:HumansCells
    60. Hurt AC, Butler J, Kelso A, Barr IG. Influenza antivirals and resistance: the next 10 years? Expert Rev Anti Infect Ther. 2012 Nov; 10(11):1221-3. PMID: 23241176.
      Citations: 4     Fields:    Translation:Humans
    61. Kelso A, Hurt AC. The ongoing battle against influenza: Drug-resistant influenza viruses: why fitness matters. Nat Med. 2012 Oct; 18(10):1470-1. PMID: 23042350.
      Citations: 15     Fields:    Translation:HumansCells
    62. Arzey GG, Kirkland PD, Arzey KE, Frost M, Maywood P, Conaty S, Hurt AC, Deng YM, Iannello P, Barr I, Dwyer DE, Ratnamohan M, McPhie K, Selleck P. Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis. 2012 May; 18(5):814-6. PMID: 22516302.
      Citations: 73     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    63. Mulley WR, Visvanathan K, Hurt AC, Brown FG, Polkinghorne KR, Mastorakos T, Lewicki MC, Stuart RL, Tan SJ, Chean R, Kerr PG, Kanellis J. Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination. Kidney Int. 2012 Jul; 82(2):212-9. PMID: 22495292.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    64. Hurt AC, Leang SK, Speers DJ, Barr IG, Maurer-Stroh S. Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses. Emerg Infect Dis. 2012 Jan; 18(1):109-12. PMID: 22260817.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    65. Okomo-Adhiambo M, Hurt AC, Gubareva LV. The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors. Methods Mol Biol. 2012; 865:95-113. PMID: 22528155.
      Citations: 6     Fields:    Translation:HumansCells
    66. Hurt AC, Okomo-Adhiambo M, Gubareva LV. The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors. Methods Mol Biol. 2012; 865:115-25. PMID: 22528156.
      Citations: 15     Fields:    Translation:HumansCells
    67. Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Gehrig N, Kelso A. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med. 2011 Dec 29; 365(26):2541-2. PMID: 22204735.
      Citations: 64     Fields:    Translation:HumansCells
    68. Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, Hayden FG, Hui DS, Hungnes O, Lackenby A, Lim W, Meijer A, Penn C, Tashiro M, Uyeki TM, Zambon M. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis. 2012 Mar; 12(3):240-8. PMID: 22186145.
      Citations: 79     Fields:    Translation:HumansCellsPHPublic Health
    69. McCaw JM, Arinaminpathy N, Hurt AC, McVernon J, McLean AR. A mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal model. PLoS Comput Biol. 2011 Apr; 7(4):e1002026. PMID: 21552544.
      Citations: 9     Fields:    Translation:HumansCells
    70. Hansbro PM, Warner S, Tracey JP, Arzey KE, Selleck P, O'Riley K, Beckett EL, Bunn C, Kirkland PD, Vijaykrishna D, Olsen B, Hurt AC. Surveillance and analysis of avian influenza viruses, Australia. Emerg Infect Dis. 2010 Dec; 16(12):1896-904. PMID: 21122219.
      Citations: 34     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    71. Hurt AC, Lowther S, Middleton D, Barr IG. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model. Antiviral Res. 2010 Sep; 87(3):361-6. PMID: 20603155.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    72. Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, Harper JM, Thursky K, Worth LJ, Dwyer DE, Morrissey CO, Johnson PD, Buising KL, Harrison SJ, Seymour JF, Ferguson PE, Wang B, Denholm JT, Cheng AC, Slavin M. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis. 2010 Jul; 16(7):1068-75. PMID: 20587176.
      Citations: 43     Fields:    Translation:HumansCellsPHPublic Health
    73. Chidlow GR, Harnett GB, Williams SH, Tempone SS, Speers DJ, Hurt AC, Deng YM, Smith DW. The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay. J Virol Methods. 2010 Oct; 169(1):47-51. PMID: 20600329.
      Citations: 11     Fields:    Translation:HumansCells
    74. Blyth CC, Foo H, van Hal SJ, Hurt AC, Barr IG, McPhie K, Armstrong PK, Rawlinson WD, Sheppeard V, Conaty S, Staff M, Dwyer DE. Influenza outbreaks during World Youth Day 2008 mass gathering. Emerg Infect Dis. 2010 May; 16(5):809-15. PMID: 20409371.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    75. Kirkland PD, Finlaison DS, Crispe E, Hurt AC. Influenza virus transmission from horses to dogs, Australia. Emerg Infect Dis. 2010 Apr; 16(4):699-702. PMID: 20350392.
      Citations: 29     Fields:    Translation:AnimalsCells
    76. Speers DJ, Williams SH, Pinder M, Moody HR, Hurt AC, Smith DW. Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case. Med J Aust. 2010 Feb 01; 192(3):166-8. PMID: 20121687.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    77. Steain MC, Dwyer DE, Hurt AC, Kol C, Saksena NK, Cunningham AL, Wang B. Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification. Antiviral Res. 2009 Dec; 84(3):242-8. PMID: 19800370.
      Citations: 8     Fields:    Translation:HumansCells
    78. Hurt AC, Holien JK, Barr IG. In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimicrob Agents Chemother. 2009 Oct; 53(10):4433-40. PMID: 19651908.
      Citations: 56     Fields:    Translation:AnimalsCells
    79. Hurt AC, Holien JK, Parker M, Kelso A, Barr IG. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol. 2009 Oct; 83(20):10366-73. PMID: 19641000.
      Citations: 97     Fields:    Translation:HumansAnimalsCells
    80. Hurt AC, Baas C, Deng YM, Roberts S, Kelso A, Barr IG. Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses. Influenza Other Respir Viruses. 2009 Jul; 3(4):171-6. PMID: 19627374.
      Citations: 47     Fields:    Translation:HumansCells
    81. Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D'Souza H, Komadina N, Shaw R, Kelso A, Barr IG. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res. 2009 Jul; 83(1):90-3. PMID: 19501261.
      Citations: 114     Fields:    Translation:HumansCells
    82. Guillonneau C, Mintern JD, Hubert FX, Hurt AC, Besra GS, Porcelli S, Barr IG, Doherty PC, Godfrey DI, Turner SJ. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc Natl Acad Sci U S A. 2009 Mar 03; 106(9):3330-5. PMID: 19211791.
      Citations: 64     Fields:    Translation:AnimalsCells
    83. Hurt AC, Holien JK, Parker MW, Barr IG. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs. 2009; 69(18):2523-31. PMID: 19943705.
      Citations: 41     Fields:    Translation:HumansCellsPHPublic Health
    84. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine. 2008 Sep 12; 26 Suppl 4:D31-4. PMID: 19230156.
      Citations: 113     Fields:    Translation:HumansCells
    85. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008 Apr 18; 320(5874):340-6. PMID: 18420927.
      Citations: 315     Fields:    Translation:HumansCellsPHPublic Health
    86. Hurt AC, Barr IG. Influenza viruses with reduced sensitivity to the neuraminidase inhibitor drugs in untreated young children. Commun Dis Intell Q Rep. 2008 Mar; 32(1):57-62. PMID: 18522305.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    87. Yun NE, Linde NS, Zacks MA, Barr IG, Hurt AC, Smith JN, Dziuba N, Holbrook MR, Zhang L, Kilpatrick JM, Arnold CS, Paessler S. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology. 2008 Apr 25; 374(1):198-209. PMID: 18234269.
      Citations: 34     Fields:    Translation:AnimalsCells
    88. Ho HT, Hurt AC, Mosse J, Barr I. Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues. Antiviral Res. 2007 Dec; 76(3):263-6. PMID: 17868928.
      Citations: 8     Fields:    Translation:Cells
    89. Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol. 2007 Jun; 39(2):132-5. PMID: 17452000.
      Citations: 68     Fields:    Translation:HumansCells
    90. Hurt AC, Ho HT, Barr I. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors. Expert Rev Anti Infect Ther. 2006 Oct; 4(5):795-805. PMID: 17140356.
      Citations: 30     Fields:    Translation:HumansAnimals
    91. Hurt AC, Iannello P, Jachno K, Komadina N, Hampson AW, Barr IG, McKimm-Breschkin JL. Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient. Antimicrob Agents Chemother. 2006 May; 50(5):1872-4. PMID: 16641465.
      Citations: 20     Fields:    Translation:HumansCells
    92. Barr IG, Komadina N, Durrant C, Sjogren H, Hurt AC, Shaw RP. Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000. Commun Dis Intell Q Rep. 2006; 30(3):350-7. PMID: 17120489.
      Citations: 14     Fields:    Translation:HumansCells
    93. Alexander R, Hurt AC, Lamb D, Wong FY, Hampson AW, Barr IG. A comparison of a rapid test for influenza with laboratory-based diagnosis in a paediatric population. Commun Dis Intell Q Rep. 2005; 29(3):272-6. PMID: 16220863.
      Citations: 2     Fields:    Translation:HumansCells
    94. Cheam AL, Barr IG, Hampson AW, Mosse J, Hurt AC. In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors. Antiviral Res. 2004 Sep; 63(3):177-81. PMID: 15451185.
      Citations: 8     Fields:    Translation:Cells
    95. Hurt AC, McKimm-Breschkin JL, McDonald M, Barr IG, Komadina N, Hampson AW. Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs. Virus Res. 2004 Jul; 103(1-2):205-11. PMID: 15163511.
      Citations: 10     Fields:    Translation:HumansCells
    96. Hurt AC, Barr IG, Komadina N, Hampson AW. A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses. Virus Res. 2004 Jul; 103(1-2):79-83. PMID: 15163493.
      Citations: 1     Fields:    Translation:HumansCells
    97. Hurt AC, Barr IG, Hartel G, Hampson AW. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res. 2004 Apr; 62(1):37-45. PMID: 15026200.
      Citations: 38     Fields:    Translation:HumansCells
    98. Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia. Commun Dis Intell Q Rep. 2003; 27(4):542-7. PMID: 15508516.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health